Clin2
NCT07313150Possibly a fitNot yet recruiting

Testing QLS7305 in healthy adults

Healthy Volunteers - Male and Female

This trial is testing a new drug called QLS7305, given as a shot under the skin, to see if it is safe in healthy adults. It may help in the future to treat certain conditions.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
60 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You must be between 18 and 55 years old.
  • You must be in good general health, with normal test results.
  • You must weigh at least 110 pounds (50 kg) if male, or 99 pounds (45 kg) if female, and have a BMI between 18 and 28.
  • You must be willing to get two vaccines (one for meningitis, one for pneumonia) as part of the study.
  • You must agree to use effective birth control for 12 months after getting the study drug (if you could become pregnant or get someone pregnant).
  • You cannot have a history of serious allergies, infections, or certain medical conditions like a removed spleen or a weak immune system.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06560593Not yet recruiting· Phase 1
Testing NTQ5082 in healthy volunteers

This trial tests a new drug called NTQ5082 in healthy people to see how safe it is and how the body processes it. If you qualify, you will help researchers understand the drug's effects before it is tested in patients with a disease.

Changsha, Hunan
NCT07522970Recruiting· Phase 1
Safety and Tolerability Study of LG-0317 in Healthy Adults

This early-stage study tests a new experimental drug called LG-0317 in healthy volunteers to see if it is safe and how the body processes it. If you are healthy and meet the basic requirements, this trial may help advance a new treatment option.

Shanghai, Shanghai Municipality
NCT07448155Recruiting· Phase 1
Testing a new drug in healthy volunteers

This study tests a new medicine (INCA033989) given as a shot or IV in healthy adults to see how the body processes it and if it's safe.

Tempe, Arizona
NCT06945445Not yet recruiting· Phase 1
Safety study of SLN12140 in healthy adults

This study tests a new drug called SLN12140 in healthy adults to see how safe it is and how the body processes it. You will need to have had certain vaccines beforehand and be willing to follow a detailed schedule of check-ups and procedures.

Shanghai, Shanghai Municipality
NCT07606976Not yet recruiting· Phase 1
Safety study of SSS68 injection in healthy adults

This is an early-stage safety test of a new injectable drug (SSS68) in healthy volunteers with no serious medical conditions. Researchers will give one dose under the skin and monitor how your body tolerates it over time.

Shanghai
NCT07152444Not yet recruiting· Phase 1
Testing QLS1410 in healthy adults and those with mild high blood pressure

This trial tests a new drug called QLS1410. It is given once to healthy volunteers and to people with mild high blood pressure to see how the body handles it and if it lowers blood pressure safely.

Beijing

Hear when a new Healthy Volunteers - Male and Female trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.